PATENT CLAIM ANALYSIS

Application Number: 15950868
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-04
Patent Classification: ["514", "546000"]

Abstract:
Genetic and epigenetic diseases and disorders are treated with FDA approved dietary compositions in the form of dietary supplements and nutraceuticals. The diseases and disorders to be treated include Rett syndrome, trinucleotide repeat diseases such as Fragile X syndrome, memory impairment, chronic inflammation, pre-cancerous conditions which involve cancer stem cells, and post-cancerous conditions which involve cancer stem cells which have survived in spite of cancer treatment. Treatment options include prophylactic treatment which is initiated prior to the development of the symptoms of the disease or disorder.

Claim (Index 12):
The method of  claim 1 , wherein administration of said composition decreases methylation at CpG islands of tumor suppressor genes in cancerous cells in said subject.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 91.0
- Lexical Diversity: 1.59322
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15950877', '15251880', '09967869', '14708045', '12521109']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7273610139582684
- 35 USC 102 Novelty (BERT): 0.6155891940018642
- Combined Prediction Score: 0.7161838319626279
- Mean Citation Score: 326.950782
- Max Citation Score: 520.8349
- Similarity Product: 513.3860665099442

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test